article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study. Anticancer Drugs Approved by the US Food and Drug Administration From 2009 to 2020 According to Their Mechanism of Action. A full posting of abstracts/summaries of these articles may be found on our? JAMA Intern Med.

COVID-19 176
article thumbnail

Unpacking Averages: Device Inspection Citations That Frequently Precede Warning Letters

Health Law Advisor

We have just gone through an extraordinary two years where, in unprecedented fashion, FDA’s inspection process was essentially shut down. Further, from a warning letter standpoint, without inspection data, FDA focused in other compliance realms than it typically might. Just a short while ago FDA recommenced inspections.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Documentation: How PDFs Can Help Providers Expedite Care

HIT Consultant

The transition toward more digital recordkeeping in healthcare began in earnest in 2009 with the passage of the American Recovery and Reinvestment Act. With mountains of paperwork generated every year, achieving complete patient privacy and 100 percent compliance can be difficult.

FDA 98
article thumbnail

Cybersecurity is Now a Patient Safety Issue, Suggests Sen. Warner In Congressional Report

HIPAA Journal

The Department of Health and Human Services (HHS) is the Sector Risk Management Agency (SRMA) for the healthcare industry, but within the HHS agencies such as the Office for Civil Rights (OCR), Centers for Medicare and Medicaid Services (CMS), and the Food and Drug Administration (FDA) have their own jurisdictions and cybersecurity policies.

HIPAA 116
article thumbnail

Uber Health Hires First Chief Medical Officer, Aledade’s New CEO, Other Digital Health Appointments

HIT Consultant

Big Health , a digital therapeutics company dedicated to helping millions back to good mental health, today announced that it has added former Food and Drug Administration (FDA) Deputy Commissioner for Medical and Scientific Affairs Dr. Anand Shah to its Board of Directors.

article thumbnail

Dealing with the Pennsylvania Supreme Court’s Non-Decision on Standards Compliance Evidence

Drug & Device Law

That is significant because, unlike (now) every other state in the country, since 1987 Pennsylvania precedent prohibited defendants from introducing evidence of their compliance with government and/or industry standards (“standards compliance” or “compliance” evidence, for short) in strict liability design defect cases – generally.

article thumbnail

Guest Post – Michigan Product Liability Law:  Retroactivity of New Law and Primer

Drug & Device Law

As the DDL blog has previously reported , Michigan’s longstanding presumption of non-defectiveness applicable to FDA-approved drugs was recently repealed by the Michigan legislature in S.B. As this provision is newly applicable to FDA-approved products, it has not been tested by the courts on this issue. 2009) (citations omitted).

FDA 52